The lancet oncology
The most recent articles from:
Lancet Oncol.
-
The lancet oncology · Feb 2018
Randomized Controlled TrialPEGPH20 for metastatic pancreatic ductal adenocarcinoma.
-
The lancet oncology · Feb 2018
Inotuzumab ozogamicin in combination with low-intensity chemotherapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia: a single-arm, phase 2 study.
Inotuzumab ozogamicin, an anti-CD22 monoclonal antibody bound to a toxin, calicheamicin, has shown single-agent activity in relapsed or refractory acute lymphoblastic leukaemia. We aimed to assess the activity and safety of inotuzumab ozogamicin in combination with low-intensity chemotherapy in older patients with acute lymphoblastic leukaemia. ⋯ MD Anderson Cancer Center.